Encompass Health Co. (NYSE:EHC) Given Consensus Rating of “Buy” by Brokerages

Shares of Encompass Health Co. (NYSE:EHC) have earned an average recommendation of “Buy” from the eleven research firms that are currently covering the stock, MarketBeat reports. Nine research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $107.11.

A number of analysts have issued reports on EHC shares. Truist Financial reiterated a “buy” rating and issued a $116.00 target price (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Barclays lifted their target price on shares of Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Royal Bank of Canada lifted their target price on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Finally, KeyCorp lifted their price target on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th.

Encompass Health Stock Performance

Shares of EHC opened at $95.93 on Friday. Encompass Health has a one year low of $70.83 and a one year high of $104.55. The company has a 50-day moving average of $96.58 and a two-hundred day moving average of $94.58. The stock has a market cap of $9.66 billion, a price-to-earnings ratio of 23.17, a PEG ratio of 1.13 and a beta of 0.89. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, topping the consensus estimate of $0.94 by $0.09. The business had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The firm’s quarterly revenue was up 11.9% compared to the same quarter last year. During the same period last year, the company posted $0.86 earnings per share. On average, equities research analysts expect that Encompass Health will post 4.29 earnings per share for the current year.

Institutional Investors Weigh In On Encompass Health

A number of institutional investors have recently bought and sold shares of the business. CIBC Asset Management Inc boosted its stake in Encompass Health by 3.5% during the third quarter. CIBC Asset Management Inc now owns 2,957 shares of the company’s stock worth $286,000 after buying an additional 100 shares in the last quarter. Miracle Mile Advisors LLC boosted its stake in shares of Encompass Health by 3.0% in the 4th quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company’s stock valued at $354,000 after purchasing an additional 112 shares in the last quarter. MassMutual Private Wealth & Trust FSB boosted its stake in shares of Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after purchasing an additional 137 shares in the last quarter. V Square Quantitative Management LLC boosted its stake in shares of Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after purchasing an additional 140 shares in the last quarter. Finally, Verdence Capital Advisors LLC lifted its position in Encompass Health by 4.6% during the 3rd quarter. Verdence Capital Advisors LLC now owns 3,670 shares of the company’s stock worth $355,000 after buying an additional 160 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.